In supplemental file S4 Fig, the labels for “controls” and “progressors” were switched. The corrected S4 Fig can be found here.
Supporting information
S4 Fig. Distribution of signature scores for the TRM5 and 3PR in the combined ACS training and test cohorts and the GC6–74 validation cohort.
Mann–Whitney test P values are shown for comparison of each signature on different progressor and nonprogressor samples run on the different SOMAscan assays. 3PR, 3-protein pair-ratio; ACS, Adolescent Cohort Study; GC6–74, Grand Challenges 6–74; SOMAscan; TRM5, TB Risk Model 5.
https://doi.org/10.1371/journal.pmed.1002880.s001
(TIF)
Reference
- 1. Penn-Nicholson A, Hraha T, Thompson EG, Sterling D, Mbandi SK, Wall KM, et al. (2019) Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study. PLoS Med 16(4): e1002781. https://doi.org/10.1371/journal.pmed.1002781 pmid:30990820
Citation: Penn-Nicholson A, Hraha T, Thompson EG, Sterling D, Mbandi SK, Wall KM, et al. (2019) Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study. PLoS Med 16(7): e1002880. https://doi.org/10.1371/journal.pmed.1002880
Published: July 18, 2019
Copyright: © 2019 Penn-Nicholson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.